Hints and tips:
Related Special Reports
...After the latter was bought by Swiss pharmaceutical group Roche in 2009, he rose through the ranks, becoming Genentech’s chief executive in 2017 and Roche’s head of pharma two years later....
...It already made its diagnostics products in the country but had “limited manufacturing for pharma”, he added....
...But the sixth-largest pharma company by global sales in 2022 has dropped the idea of a pivotal trial involving 40,000 UK patients, “after a careful evaluation of several factors that drive investment decisions...
...He added that the underlying operative problems in the pharma and crop science businesses needed to be addressed without undue job cuts....
...The crunchy acronym was coined by Goldman Sachs for pharma companies GSK and Roche, Dutch chip company ASML, Switzerland’s Nestlé and Novartis, Danish drugmaker Novo Nordisk, France’s L’Oréal and LVMH, the...
...The company also faces the expiration of key patents in its pharma division and last year aborted a late-stage trial of its most hopeful new drugs....
The Swiss pharma group needs to settle investor jitters with its latest acquisition
...Chief executive Bill Anderson, who joined last year after heading the pharma unit of Swiss rival Roche, said the decision “was not taken lightly” and had “considered investor input.”...
...US President Joe Biden has put his fight against Big Pharma at the centre of his re-election campaign, championing his efforts to lower drug prices through the Inflation Reduction Act....
...This raises funds for Schott AG’s green transition and gives Schott Pharma a chance to tap the capital markets if opportunities arise. The size of the offer is undecided....
...Manns said asundexian was the most promising drug in Bayer’s pharma pipeline. “Without it, the pharma unit is left without sustainable growth.”...
...The new chief executive, who has been in the job since the summer and previously ran Roche’s pharma division, disagreed that Bayer’s pharma unit was too small to keep up with larger rivals....
...Last month he blasted Bayer’s performance as “unacceptable” and stressed that “all options” were on the table, including splitting the pharma unit from the crop science division....
...It’s a spoiler for Wall Street and Big Ag, and Big Tech, and Big Telecom, and Big Pharma, and the corporate- owned media and all the corrupt politicians and corporations.”...
Swiss pharma group acquires rights to develop and manufacture bowel disease treatment
...Yet the German conglomerate is making rapid moves in its pharma division....
...You could imagine tweaking the chemistry to address other targets,” said Michael Lobritz, global head of infectious diseases at Roche Pharma Research & Early Development....
...But pressure is mounting on pharma companies to switch to synthetic substances as populations decline for horseshoe crabs and seabirds that eat the creatures’ eggs....
...Shares in large pharma companies that are also developing anti-TIGITs rose....
...Mercedes has since 2019 been betting on the premium end of the market, which Schwarz said had moved the German group further away from rivalry with Tesla and BYD....
...But Bayer’s persistently low multiple against agrochemical and pharma peers underscores the need for change. Anderson wishes to boost pharma, for example, by removing centralised research budgeting....
Vas Narasimhan warns giving Brussels power over drug manufacturing during crises will hit investment
...The reforms have prompted a furious backlash from the pharma industry, which has warned that these would cripple innovation and hinder development of life-saving medicines....
...At a rally in Philadelphia, Kennedy attacked Wall Street, corporations, “Big Tech”, “Big Ag”, “Big Pharma”, the military-industrial complex and “the mercenary media”....
...His successor Anderson, who previously oversaw the pharma business of Swiss rival Roche, praised the industrial logic of the Monsanto acquisition....
International Edition